{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:55:02Z","timestamp":1781639702118,"version":"3.54.5"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>\n                      The International Diabetes Federation projects a prevalence of 783.2\u00a0million cases of type 2 diabetes mellitus (T2DM) by 2045. The escalation in healthcare expenditure and adverse effects of current drugs necessitate a clinically effective and low-cost alternative therapeutic option with minimal health complications.\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      spp., a well-studied gut probiotic has shown promising antidiabetic effects against T2DM in several randomized controlled trials. However, the exact mechanisms of\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      spp. in regulating the glycaemic profile are not well elucidated, limiting the optimization of probiotic-based interventions. Therefore, this paper aims to explore the various antidiabetic mechanisms of\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      spp., with a focus on their integration into precision medicine approaches.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      spp. supplementation alleviates insulin resistance in T2DM by modulating glucose metabolism and transport, exerting anti-inflammatory and anti-oxidative effects as well as restructuring gut microbiota.\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      spp. also enhance the functional properties of food by increasing the antioxidant capacity and improving glucose metabolism. Despite these promising effects, clinical translation is challenged by strain-specific survivability in the gastrointestinal tract and safety concerns. Thus, leveraging precision medicine via tailoring treatments based on individual microbiome profiles, genetic backgrounds and metabolic phenotype may unravel the full therapeutic potential of targeted\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      spp. for T2DM treatment. This approach can be reached by integrating multi-omics profiling and artificial intelligence technologies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Lactobacillus spp. may act as adjunctive support in the management T2DM rather than stand-alone therapies in T2DM management, as their efficacy is dependent on appropriate dietary interventions and metabolic context. Altogether, integrating Lactobacillus spp. into personalized treatment frameworks offers a promising avenue for developing more targeted, effective and safe interventions for T2DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13668-026-00739-3","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:43:01Z","timestamp":1772610181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision Microbiome Modulation: Exploring Lactobacillus spp. as A Targeted Strategy for Type 2 Diabetes Management"],"prefix":"10.1007","volume":"15","author":[{"given":"Ann Sze","family":"Cheah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizul","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-9293","authenticated-orcid":false,"given":"Wendy Wai Yeng","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"7","key":"739_CR1","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/foods10071455","volume":"10","author":"P Toejing","year":"2021","unstructured":"Toejing P, Khampithum N, Sirilun S, Chaiyasut C, Lailerd N. Influence of Lactobacillus paracasei HII01 supplementation on glycemia and inflammatory biomarkers in type 2 diabetes: a randomized clinical trial. Foods. 2021;10(7):1455.","journal-title":"Foods"},{"issue":"17","key":"739_CR2","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"739_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","volume":"16","author":"P Farmaki","year":"2020","unstructured":"Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E. Complications of the type 2 diabetes mellitus. Curr Cardiol Rev. 2020;16(4):249\u201351.","journal-title":"Curr Cardiol Rev"},{"issue":"5","key":"739_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00203-020-01818-x","volume":"202","author":"MSH Akash","year":"2020","unstructured":"Akash MSH, Rehman K, Fiayyaz F, Sabir S, Khurshid M. Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies, (in eng). Arch Microbiol. 2020;202(5):953\u201365. https:\/\/doi.org\/10.1007\/s00203-020-01818-x","journal-title":"Arch Microbiol"},{"issue":"1","key":"739_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-016-0303-y","volume":"23","author":"K Rehman","year":"2016","unstructured":"Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? (in eng). J Biomed Sci. 2016;23(1):87. https:\/\/doi.org\/10.1186\/s12929-016-0303-y","journal-title":"J Biomed Sci"},{"issue":"11","key":"739_CR6","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1002\/jcb.26097","volume":"118","author":"K Rehman","year":"2017","unstructured":"Rehman K, Akash MSH Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked? (in eng). J Cell Biochem. 2017;118(11):3577\u201385. https:\/\/doi.org\/10.1002\/jcb.26097.","journal-title":"J Cell Biochem"},{"key":"739_CR7","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. 2022\/01\/01. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"739_CR8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","volume":"8","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Chen Y, Huang W, Zhou H, Zhang W Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduct Target Ther. 2023;8(1):386. https:\/\/doi.org\/10.1038\/s41392-023-01619-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"739_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/ph14080806","volume":"14","author":"J Blahova","year":"2021","unstructured":"Blahova J, Martiniakova M, Babikova M, Kovacova V, Mondockova V, Omelka R. Pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus. Pharmaceuticals. 2021;14;8:806.","journal-title":"Pharmaceuticals"},{"issue":"7","key":"739_CR10","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.3390\/app11073091","volume":"11","author":"YJ Hyun","year":"2021","unstructured":"Hyun YJ, Kim JG, Jung SK, Kim JY. Fermented rice germ extract ameliorates abnormal glucose metabolism via antioxidant activity in type 2 diabetes mellitus mice. Appl Sci. 2021;11(7):3091.","journal-title":"Appl Sci"},{"issue":"11","key":"739_CR11","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1111\/cts.13640","volume":"16","author":"CC Kang","year":"2023","unstructured":"Kang CC, Lee TY, Lim WF, Yeo WWY. Opportunities and challenges of 5G network technology toward precision medicine. Clin Transl Sci. 2023;16(11):2078\u201394. https:\/\/doi.org\/10.1111\/cts.13640.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"739_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1757-4749-4-16","volume":"4","author":"R Saad","year":"2012","unstructured":"Saad R, Rizkallah MR, Aziz RK. Gut pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes. Gut Pathog. 2012;4(1):16. https:\/\/doi.org\/10.1186\/1757-4749-4-16.","journal-title":"Gut Pathog"},{"key":"739_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa292","author":"R Hassan","year":"2021","unstructured":"Hassan R, et al. Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbaa292.","journal-title":"Brief Bioinform"},{"issue":"6","key":"739_CR14","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101986R","volume":"36","author":"IJ Dikeocha","year":"2022","unstructured":"Dikeocha IJ, Al-Kabsi AM, Miftahussurur M, Alshawsh MA. Pharmacomicrobiomics: influence of gut microbiota on drug and xenobiotic metabolism. FASEB J. 2022;36(6):e22350. https:\/\/doi.org\/10.1096\/fj.202101986R.","journal-title":"FASEB J"},{"key":"739_CR15","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","volume":"51","author":"M Gurung","year":"2020","unstructured":"Gurung M, et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:102590. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.051.","journal-title":"EBioMedicine"},{"issue":"5","key":"739_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","volume":"22","author":"AK DeGruttola","year":"2016","unstructured":"DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22(5):1137\u201350.","journal-title":"Inflamm Bowel Dis"},{"issue":"7418","key":"739_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55\u201360. https:\/\/doi.org\/10.1038\/nature11450.","journal-title":"Nature"},{"issue":"8","key":"739_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews Gastroenterology & hepatology. 2014;11(8):506\u201314.","journal-title":"Nature reviews Gastroenterology & hepatology"},{"issue":"33","key":"739_CR19","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.3748\/wjg.v26.i33.4919","volume":"26","author":"E Russo","year":"2020","unstructured":"Russo E, Nannini G, Dinu M, Pagliai G, Sofi F, Amedei A. Exploring the food-gut axis in immunotherapy response of cancer patients. World J Gastroenterol. 2020;26(33):4919.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 2","key":"739_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12262-022-03318-2","volume":"84","author":"J Xu","year":"2022","unstructured":"Xu J, Xu Y, Song Y. Efficacy of probiotics supplementation on the prognosis of patients after liver transplantation: a systematic review and Meta-Analysis. Indian J Surg. 2022;84(Suppl 2):409\u201317.","journal-title":"Indian J Surg"},{"key":"739_CR21","doi-asserted-by":"publisher","first-page":"1085041","DOI":"10.3389\/fendo.2023.1085041","volume":"14","author":"J Zhen","year":"2023","unstructured":"Zhen J, et al. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases. Front Endocrinol. 2023;14:1085041.","journal-title":"Front Endocrinol"},{"key":"739_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5281639","author":"Y Yue","year":"2020","unstructured":"Yue Y, et al. Stable colonization of orally administered Lactobacillus casei SY13 alters the gut microbiota. Biomed Res Int. 2020. https:\/\/doi.org\/10.1155\/2020\/5281639.","journal-title":"Biomed Res Int"},{"issue":"2","key":"739_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.clnu.2021.11.037","volume":"41","author":"C Zhang","year":"2022","unstructured":"Zhang C, et al. Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults. Clin Nutr. 2022;41(2):365\u201373.","journal-title":"Clin Nutr"},{"key":"739_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1248518","volume":"11","author":"S Chen","year":"2023","unstructured":"Chen S, Zhang Y. Mechanism and application of Lactobacillus in type 2 diabetes-associated periodontitis. Front Public Health. 2023;11:1248518. https:\/\/doi.org\/10.3389\/fpubh.2023.1248518.","journal-title":"Front Public Health"},{"key":"739_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.693412","volume":"8","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhong X, Liu X, Wang X, Gao X. Therapeutic and improving function of Lactobacilli in the prevention and treatment of cardiovascular-related diseases: a novel perspective from gut microbiota. Front Nutr. 2021;8:693412. https:\/\/doi.org\/10.3389\/fnut.2021.693412.","journal-title":"Front Nutr"},{"key":"739_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020288","author":"JJ Jeong","year":"2022","unstructured":"Jeong JJ, et al. The Lactobacillus as a probiotic: focusing on liver diseases. Microorganisms. 2022. https:\/\/doi.org\/10.3390\/microorganisms10020288.","journal-title":"Microorganisms"},{"key":"739_CR27","doi-asserted-by":"publisher","first-page":"1042189","DOI":"10.3389\/fphar.2022.1042189","volume":"13","author":"S Rastogi","year":"2022","unstructured":"Rastogi S, Singh A. Gut microbiome and human health: exploring how the probiotic genus Lactobacillus modulate immune responses. Front Pharmacol. 2022;13:1042189.","journal-title":"Front Pharmacol"},{"issue":"1","key":"739_CR28","doi-asserted-by":"publisher","first-page":"16791","DOI":"10.1038\/s41598-018-35014-1","volume":"8","author":"M-C Hsieh","year":"2018","unstructured":"Hsieh M-C, et al. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Sci Rep. 2018;8(1):16791.","journal-title":"Sci Rep"},{"issue":"1","key":"739_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.29252\/ibj.23.1.68","volume":"23","author":"L Khalili","year":"2019","unstructured":"Khalili L, et al. The effects of Lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-a levels in patients with type 2 diabetes mellitus: a randomized controlled trial. Iran Biomed J. 2019;23(1):68.","journal-title":"Iran Biomed J"},{"issue":"7","key":"739_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072337","volume":"13","author":"M-R Oh","year":"2021","unstructured":"Oh M-R, et al. Lactobacillus plantarum HAC01 supplementation improves glycemic control in prediabetic subjects: a randomized, double-blind, placebo-controlled trial. Nutrients. 2021;13(7):2337.","journal-title":"Nutrients"},{"issue":"2","key":"739_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020374","volume":"12","author":"T Toshimitsu","year":"2020","unstructured":"Toshimitsu T, et al. Effects of 12-week ingestion of yogurt containing Lactobacillus plantarum OLL2712 on glucose metabolism and chronic inflammation in prediabetic adults: a randomized placebo-controlled trial. Nutrients. 2020;12(2):374.","journal-title":"Nutrients"},{"issue":"7","key":"739_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8070969","volume":"8","author":"H Kim","year":"2020","unstructured":"Kim H, Kim T, Kang J, Kim Y, Kim H. Is Lactobacillus gram-positive? A case study of Lactobacillus iners. Microorganisms. 2020;8(7):969.","journal-title":"Microorganisms"},{"key":"739_CR33","doi-asserted-by":"publisher","first-page":"2050313X2311527","DOI":"10.1177\/2050313X231152709","volume":"11","author":"E DeMarco","year":"2023","unstructured":"DeMarco E, DePetrillo J, Qadeer F. Meropenem resistant Lactobacillus endocarditis in an immunocompetent patient. SAGE Open Medical Case Reports. 2023;11:2050313X231152709.","journal-title":"SAGE Open Medical Case Reports"},{"key":"739_CR34","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1007\/s00253-018-9217-9","volume":"102","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Lv J, Pan L, Zhang Y. Roles and applications of probiotic Lactobacillus strains. Appl Microbiol Biotechnol. 2018;102:8135\u201343.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"739_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1822729","volume":"12","author":"TS Ghosh","year":"2020","unstructured":"Ghosh TS, Arnoux J, O\u2019Toole PW. Metagenomic analysis reveals distinct patterns of gut lactobacillus prevalence, abundance, and geographical variation in health and disease. Gut Microbes. 2020;12(1):1822729.","journal-title":"Gut Microbes"},{"issue":"3","key":"739_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.eng.2020.06.026","volume":"7","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Lactobacillus plantarum CCFM8610 alleviates irritable bowel syndrome and prevents gut microbiota dysbiosis: a randomized, double-blind, placebo-controlled, pilot clinical trial. Engineering. 2021;7(3):376\u201385.","journal-title":"Engineering"},{"issue":"3","key":"739_CR37","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/fsn3.2145","volume":"9","author":"SJ Masoumi","year":"2021","unstructured":"Masoumi SJ, Mehrabani D, Saberifiroozi M, Fattahi MR, Moradi F, Najafi M. The effect of yogurt fortified with Lactobacillus acidophilus and bifidobacterium sp. probiotic in patients with lactose intolerance. Food Sci Nutr. 2021;9(3):1704\u201311.","journal-title":"Food Sci Nutr"},{"key":"739_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746585","author":"B Yang","year":"2021","unstructured":"Yang B, et al. Lactobacillus plantarum CCFM1143 alleviates chronic diarrhea via inflammation regulation and gut microbiota modulation: a double-blind, randomized, placebo-controlled study. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.746585.","journal-title":"Front Immunol"},{"key":"739_CR39","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-458","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zhang Y, Ma K, Wang G, Tang M, Wang R, Xia Z, Xu Z, Sun M, Bao X, Gui H, Wang H. Lactobacillus plantarum Lp3a improves functional constipation: evidence from a human randomized clinical trial and animal model. Ann Transl Med. 2022;10(6):316. https:\/\/doi.org\/10.21037\/atm-22-458.","journal-title":"Ann Transl Med"},{"issue":"1","key":"739_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41598-019-57210-3","volume":"10","author":"FA Ameen","year":"2020","unstructured":"Ameen FA, Hamdan AM, El-Naggar MY. Assessment of the heavy metal bioremediation efficiency of the novel marine lactic acid bacterium, Lactobacillus plantarum MF042018. Sci Rep. 2020;10(1):314.","journal-title":"Sci Rep"},{"issue":"7","key":"739_CR41","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00203-020-01916-w","volume":"202","author":"S Hasr Moradi Kargar","year":"2020","unstructured":"Hasr Moradi Kargar S, Hadizadeh Shirazi N. Lactobacillus fermentum and Lactobacillus plantarum bioremediation ability assessment for copper and zinc. Arch Microbiol. 2020;202(7):1957\u201363.","journal-title":"Arch Microbiol"},{"key":"739_CR42","doi-asserted-by":"crossref","unstructured":"Nugraha H, Rinanti A, Wijayanti A, Aphirta S. Bioremediation of iron and manganese heavy metal polluted soil by mixed culture of Acetobacter tropicalis and Lactobacillus fermentum, in IOP Conference Series: Earth and Environmental Science. 2023;1203(1):012006. IOP Publishing.","DOI":"10.1088\/1755-1315\/1203\/1\/012006"},{"key":"739_CR43","doi-asserted-by":"publisher","unstructured":"L\u00ea K-A et al. Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population, (in English). Front Physiol Original Res 2013;3 2013-January-31. https:\/\/doi.org\/10.3389\/fphys.2012.00496.","DOI":"10.3389\/fphys.2012.00496"},{"issue":"8","key":"739_CR44","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.2337\/dc13-2817","volume":"37","author":"J Sato","year":"2014","unstructured":"Sato J, et al. Gut dysbiosis and detection of \u201clive gut bacteria\u201d in blood of Japanese patients with type 2 diabetes. Diabetes Care. 2014;37(8):2343\u201350.","journal-title":"Diabetes Care"},{"issue":"1","key":"739_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1017\/S0007114516001045","volume":"116","author":"M Candela","year":"2016","unstructured":"Candela M, et al. Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet. Br J Nutr. 2016;116(1):80\u201393.","journal-title":"Br J Nutr"},{"key":"739_CR46","doi-asserted-by":"publisher","unstructured":"Bhute SS, Suryavanshi MV, Joshi SM, Yajnik CS, Shouche YS, Ghaskadbi SS. Gut Microbial Diversity Assessment of Indian Type-2-Diabetics Reveals Alterations in Eubacteria, Archaea, and Eukaryotes, (in English). Frontiers in Microbiology, Original Research 2017;8 2017-February-14. https:\/\/doi.org\/10.3389\/fmicb.2017.00214.","DOI":"10.3389\/fmicb.2017.00214"},{"key":"739_CR47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.micpath.2017.08.038","volume":"111","author":"M Sedighi","year":"2017","unstructured":"Sedighi M, et al. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb Pathog. 2017;111:362\u20139. https:\/\/doi.org\/10.1016\/j.micpath.2017.08.038.","journal-title":"Microb Pathog"},{"key":"739_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nut.2018.11.019","volume":"63","author":"P-C Chen","year":"2019","unstructured":"Chen P-C, Chien Y-W, Yang S-C. The alteration of gut microbiota in newly diagnosed type 2 diabetic patients. Nutrition. 2019;63:51\u20136.","journal-title":"Nutrition"},{"key":"739_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40200-020-00502-7","volume":"19","author":"H-S Ejtahed","year":"2020","unstructured":"Ejtahed H-S, et al. Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults. J Diabetes Metabolic Disorders. 2020;19:265\u201371.","journal-title":"J Diabetes Metabolic Disorders"},{"issue":"2","key":"739_CR50","doi-asserted-by":"publisher","first-page":"e00578","DOI":"10.1128\/mSystems.00578-19","volume":"5","author":"AH Gaike","year":"2020","unstructured":"Gaike AH, et al. The gut microbial diversity of newly diagnosed diabetics but not of prediabetics is significantly different from that of healthy nondiabetics. Msystems. 2020;5(2):e00578\u201319.","journal-title":"Msystems"},{"issue":"6","key":"739_CR51","doi-asserted-by":"publisher","first-page":"107561","DOI":"10.1016\/j.jdiacomp.2020.107561","volume":"34","author":"S Penckofer","year":"2020","unstructured":"Penckofer S, Limeira R, Joyce C, Grzesiak M, Thomas-White K, Wolfe AJ. Characteristics of the microbiota in the urine of women with type 2 diabetes. J Diabetes Complicat. 2020;34(6):107561.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"739_CR52","doi-asserted-by":"publisher","first-page":"e0227373","DOI":"10.1371\/journal.pone.0227373","volume":"15","author":"M Lecronier","year":"2020","unstructured":"Lecronier M, et al. Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients. PLoS ONE. 2020;15(1):e0227373.","journal-title":"PLoS ONE"},{"issue":"23","key":"739_CR53","doi-asserted-by":"publisher","first-page":"15023","DOI":"10.3390\/ijms232315023","volume":"23","author":"G Gradisteanu Pircalabioru","year":"2022","unstructured":"Gradisteanu Pircalabioru G, Chifiriuc M-C, Picu A, Petcu LM, Trandafir M, Savu O. Snapshot into the type-2-diabetes-associated microbiome of a romanian cohort. Int J Mol Sci. 2022;23(23):15023. https:\/\/www.mdpi.com\/1422-0067\/23\/23\/15023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"739_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5742\/MEWFM.2018.93316","volume":"16","author":"A Aliloo","year":"2018","unstructured":"Aliloo A, Arbabi S, Aliasgharzadeh A, Ghotaslou R. Comparison of Bifidobacterium spp. And Lactobacillus spp. Count in faeces of patients with type 2 diabetes mellitus And healthy people. World Family Med. 2018;16(3):102\u20136. https:\/\/doi.org\/10.5742\/mewfm.2018.93316.","journal-title":"World Family Med"},{"issue":"6","key":"739_CR55","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2174\/1573399815666190206162143","volume":"15","author":"MR Halawa","year":"2019","unstructured":"Halawa MR, El-Salam MA, Mostafa BM, Sallout SS. The gut microbiome, Lactobacillus acidophilus; relation with type 2 diabetes mellitus. Curr Diabetes Rev. 2019;15(6):480\u20135.","journal-title":"Curr Diabetes Rev"},{"issue":"8","key":"739_CR56","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.37358\/RC.18.8.6512","volume":"69","author":"AI Suceveanu","year":"2018","unstructured":"Suceveanu AI, et al. Gut microbiota patterns in obese and type 2 diabetes (T2D) patients from Romanian black sea Coast region. Rev Chim. 2018;69(8):2260\u20137.","journal-title":"Rev Chim"},{"key":"739_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.958218","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, et al. Gut microbiota: a new target for T2DM prevention and treatment. Front Endocrinol (Lausanne). 2022;13:958218. https:\/\/doi.org\/10.3389\/fendo.2022.958218.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"739_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82726-y","volume":"11","author":"F Durazzi","year":"2021","unstructured":"Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A. Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Sci Rep. 2021;11(1):3030. https:\/\/doi.org\/10.1038\/s41598-021-82726-y.","journal-title":"Sci Rep"},{"key":"739_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/foods12051023","author":"M Mazhar","year":"2023","unstructured":"Mazhar M, Zhu Y, Qin L. The interplay of dietary fibers and intestinal microbiota affects type 2 diabetes by generating short-chain fatty acids. Foods. 2023. https:\/\/doi.org\/10.3390\/foods12051023.","journal-title":"Foods"},{"key":"739_CR60","doi-asserted-by":"publisher","first-page":"101805","DOI":"10.1016\/j.molmet.2023.101805","volume":"77","author":"P Pavlo","year":"2023","unstructured":"Pavlo P, Kamyshna I, Kamyshnyi A. Effects of metformin on the gut microbiota: a systematic review. Mol Metab. 2023;77:101805. https:\/\/doi.org\/10.1016\/j.molmet.2023.101805.","journal-title":"Mol Metab"},{"key":"739_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2025.100496","volume":"9","author":"Y Nami","year":"2025","unstructured":"Nami Y, Shaghaghi Ranjbar M, Modarres Aval M, Haghshenas B. Harnessing Lactobacillus-derived SCFAs for food and health: pathways, genes, and functional implications. Curr Res Microb Sci. 2025;9:100496. https:\/\/doi.org\/10.1016\/j.crmicr.2025.100496.","journal-title":"Curr Res Microb Sci"},{"issue":"10","key":"739_CR62","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41591-018-0164-x","volume":"24","author":"Y He","year":"2018","unstructured":"He Y, et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models, (in eng). Nat Med. 2018;24(10):1532\u20135. https:\/\/doi.org\/10.1038\/s41591-018-0164-x","journal-title":"Nat Med"},{"issue":"10","key":"739_CR63","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-018-0160-1","volume":"24","author":"M Deschasaux","year":"2018","unstructured":"Deschasaux M, et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med. 2018;24(10):1526\u201331. https:\/\/doi.org\/10.1038\/s41591-018-0160-1.","journal-title":"Nat Med"},{"key":"739_CR64","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7502","volume":"7","author":"N Hasan","year":"2019","unstructured":"Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019;7:e7502. https:\/\/doi.org\/10.7717\/peerj.7502.","journal-title":"PeerJ"},{"issue":"2","key":"739_CR65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12602-017-9299-1","volume":"10","author":"R Tabrizi","year":"2018","unstructured":"Tabrizi R, et al. The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Probiotics Antimicrob Proteins. 2018;10(2):329\u201342. https:\/\/doi.org\/10.1007\/s12602-017-9299-1.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"739_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.742394","volume":"8","author":"HQ Chen","year":"2021","unstructured":"Chen HQ, Gong JY, Xing K, Liu MZ, Ren H, Luo JQ. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in antihypertensive treatment. Front Med (Lausanne). 2021;8:742394. https:\/\/doi.org\/10.3389\/fmed.2021.742394.","journal-title":"Front Med (Lausanne)"},{"key":"739_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/nu11071613","author":"RD Hills Jr.","year":"2019","unstructured":"Hills RD Jr., Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut microbiome: profound implications for diet and disease. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11071613.","journal-title":"Nutrients"},{"key":"739_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.humic.2019.100069","author":"KV Johnson","year":"2020","unstructured":"Johnson KV. Gut microbiome composition and diversity are related to human personality traits. Hum Microbiome J. 2020. https:\/\/doi.org\/10.1016\/j.humic.2019.100069.","journal-title":"Hum Microbiome J"},{"issue":"1","key":"739_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18871-1","volume":"11","author":"O Manor","year":"2020","unstructured":"Manor O, et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020;11(1):5206. https:\/\/doi.org\/10.1038\/s41467-020-18871-1.","journal-title":"Nat Commun"},{"issue":"4","key":"739_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/biology10040348","volume":"10","author":"A Gulnaz","year":"2021","unstructured":"Gulnaz A, et al. Lactobacillus SPS in reducing the risk of diabetes in high-fat diet-induced diabetic mice by modulating the gut microbiome and inhibiting key digestive enzymes associated with diabetes. Biology. 2021;10(4):348.","journal-title":"Biology"},{"issue":"8","key":"739_CR71","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1007\/s00284-021-02588-5","volume":"78","author":"G Won","year":"2021","unstructured":"Won G, Choi S-I, Park N, Kim J-E, Kang C-H, Kim G-H. In vitro antidiabetic, antioxidant activity, and probiotic activities of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei strains. Curr Microbiol. 2021;78(8):3181\u201391.","journal-title":"Curr Microbiol"},{"key":"739_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071098","author":"M Yang","year":"2023","unstructured":"Yang M, et al. \u201cGlucagon promotes gluconeogenesis through the GCGR\/PKA\/CREB\/PGC-1\u03b1 pathway in hepatocytes of the Japanese flounder Paralichthys olivaceus,.\u201d Cells. 2023. https:\/\/doi.org\/10.3390\/cells12071098.","journal-title":"Cells"},{"key":"739_CR73","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature03967","volume":"437","author":"SH Koo","year":"2005","unstructured":"Koo SH, et al The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism, (in eng). Nature. 2005;437:1109\u201311. https:\/\/doi.org\/10.1038\/nature03967.","journal-title":"Nature"},{"issue":"31","key":"739_CR74","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1021\/acs.jafc.1c02925","volume":"69","author":"T Wu","year":"2021","unstructured":"Wu T, et al. Lactobacillus rhamnosus LRa05 ameliorate hyperglycemia through a regulating glucagon-mediated signaling pathway and gut microbiota in type 2 diabetic mice. J Agric Food Chem. 2021;69(31):8797\u2013806.","journal-title":"J Agric Food Chem"},{"issue":"18","key":"739_CR75","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.1039\/D1FO00882J","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Lactobacillus casei LC89 exerts antidiabetic effects through regulating hepatic glucagon response and gut microbiota in type 2 diabetic mice. Food & Function. 2021;12(18):8288\u201399.","journal-title":"Food & Function"},{"issue":"14","key":"739_CR76","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1039\/D1FO00698C","volume":"12","author":"Y-S Lee","year":"2021","unstructured":"Lee Y-S, et al. Lactobacillus plantarum HAC01 ameliorates type 2 diabetes in high-fat diet and streptozotocin-induced diabetic mice in association with modulating the gut microbiota. Food & Function. 2021;12(14):6363\u201373.","journal-title":"Food & Function"},{"issue":"9","key":"739_CR77","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1039\/C9FO01062A","volume":"10","author":"F Yan","year":"2019","unstructured":"Yan F, et al. Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice. Food Funct. 2019;10(9):5804\u201315.","journal-title":"Food Funct"},{"key":"739_CR78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nutres.2020.11.008","volume":"86","author":"M Primec","year":"2021","unstructured":"Primec M, \u0160korjanc D, Langerholc T, Mi\u010deti\u0107-Turk D, Gorenjak M. Specific Lactobacillus probiotic strains decrease transepithelial glucose transport through GLUT2 downregulation in intestinal epithelial cell models. Nutr Res. 2021;86:10\u201322.","journal-title":"Nutr Res"},{"issue":"1","key":"739_CR79","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001028","volume":"8","author":"P-S Hsieh","year":"2020","unstructured":"Hsieh P-S, et al. Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db\/db mice. BMJ Open Diabetes Res Care. 2020;8(1):e001028.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"739_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55050207","volume":"55","author":"OA Korkmaz","year":"2019","unstructured":"Korkmaz OA, et al. Effects of Lactobacillus plantarum and Lactobacillus helveticus on renal insulin signaling, inflammatory markers, and glucose transporters in high-fructose-fed rats. Medicina. 2019;55(5):207.","journal-title":"Medicina"},{"issue":"3","key":"739_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031385","volume":"23","author":"L Matuschik","year":"2022","unstructured":"Matuschik L, et al. Hyperglycemia induces inflammatory response of human macrophages to CD163-mediated scavenging of hemoglobin-haptoglobin complexes. Int J Mol Sci. 2022;23(3):1385.","journal-title":"Int J Mol Sci"},{"key":"739_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11329","author":"H Bashir","year":"2022","unstructured":"Bashir H, et al. \u201cInter-relationship of pro-and anti-inflammatory biomarkers with the development of type 2 diabetes mellitus,.\u201d Heliyon. 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11329.","journal-title":"Heliyon"},{"key":"739_CR83","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.biopha.2018.06.044","volume":"106","author":"MSH Akash","year":"2018","unstructured":"Akash MSH, Rehman K, Liaqat A, Numan M, Mahmood Q, Kamal S. Biochemical investigation of gender-specific association between insulin resistance and inflammatory biomarkers in types 2 diabetic patients. Biomed Pharmacother. 2018;106:285\u201391.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"739_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40987-8","volume":"9","author":"S Kanmani","year":"2019","unstructured":"Kanmani S, Kwon M, Shin M-K, Kim MK. Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study. Sci Rep. 2019;9(1):4573.","journal-title":"Sci Rep"},{"issue":"1","key":"739_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-017-0159-5","volume":"17","author":"A Pan","year":"2017","unstructured":"Pan A, Wang Y, Yuan J-M, Koh W-P. High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case\u2013control study nested within the Singapore Chinese health study. BMC Endocr Disord. 2017;17(1):1\u20138.","journal-title":"BMC Endocr Disord"},{"key":"739_CR86","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00394-018-1753-7","volume":"58","author":"M Son","year":"2019","unstructured":"Son M, Wu J. Egg white hydrolysate and peptide reverse insulin resistance associated with tumor necrosis factor-\u03b1 (TNF-\u03b1) stimulated mitogen-activated protein kinase (MAPK) pathway in skeletal muscle cells. Eur J Nutr. 2019;58:1961\u20139.","journal-title":"Eur J Nutr"},{"issue":"2","key":"739_CR87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.59566\/IJBS.2010.6135","volume":"6","author":"E Confalone","year":"2010","unstructured":"Confalone E, D\u2019Alessio G, Furia A. IL-6 induction by TNF\u03b1 and IL-1\u03b2 in an osteoblast-like cell line. Int J Biomed Sci. 2010;6(2):135.","journal-title":"Int J Biomed Sci"},{"key":"739_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2746-7","volume":"16","author":"K Oh","year":"2016","unstructured":"Oh K, Lee O-Y, Park Y, Seo MW, Lee D-S. IL-1\u03b2 induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells. BMC Cancer. 2016;16:1\u201311.","journal-title":"BMC Cancer"},{"issue":"1","key":"739_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/srep46750","volume":"7","author":"MA Kurauti","year":"2017","unstructured":"Kurauti MA, et al. Interleukin-6 increases the expression and activity of insulin-degrading enzyme. Sci Rep. 2017;7(1):46750.","journal-title":"Sci Rep"},{"issue":"16","key":"739_CR90","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.3390\/ijms22168590","volume":"22","author":"M Khalid","year":"2021","unstructured":"Khalid M, Alkaabi J, Khan MA, Adem A. Insulin signal transduction perturbations in insulin resistance. Int J Mol Sci. 2021;22(16):8590.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"739_CR91","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1039\/C7FO00593H","volume":"8","author":"G Wang","year":"2017","unstructured":"Wang G, Li X, Zhao J, Zhang H, Chen W. Lactobacillus casei CCFM419 attenuates type 2 diabetes via a gut microbiota dependent mechanism. Food Funct. 2017;8(9):3155\u201364.","journal-title":"Food Funct"},{"key":"739_CR92","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejphar.2018.05.003","volume":"831","author":"M Li","year":"2018","unstructured":"Li M, van Esch BC, Wagenaar GT, Garssen J, Folkerts G, Henricks PA. Pro-and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol. 2018;831:52\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"18","key":"739_CR93","doi-asserted-by":"publisher","first-page":"8504","DOI":"10.1039\/D3FO01701J","volume":"14","author":"S Jiang","year":"2023","unstructured":"Jiang S, et al. Lactobacillus gasseri CKCC1913 mediated modulation of the gut\u2013liver axis alleviated insulin resistance and liver damage induced by type 2 diabetes. Food Funct. 2023;14(18):8504\u201320.","journal-title":"Food Funct"},{"issue":"1","key":"739_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-021-05706-5","volume":"14","author":"F Bootorabi","year":"2021","unstructured":"Bootorabi F, et al. Gut micobiota alteration by Lactobacillus rhamnosus reduces pro-inflammatory cytokines and glucose level in the adult model of Zebrafish. BMC Res Notes. 2021;14(1):1\u20138.","journal-title":"BMC Res Notes"},{"issue":"4","key":"739_CR95","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1007\/s12602-021-09744-0","volume":"13","author":"AC Archer","year":"2021","unstructured":"Archer AC, Muthukumar SP, Halami PM. Lactobacillus fermentum MCC2759 and MCC2760 alleviate inflammation and intestinal function in high-fat diet-fed and streptozotocin-induced diabetic rats. Probiotics Antimicrob Proteins. 2021;13(4):1068\u201380.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"739_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1081778","volume":"9","author":"M Han","year":"2023","unstructured":"Han M, Liao W, Dong Y, Bai C, Gai Z. Lacticaseibacillus rhamnosus Hao9 exerts antidiabetic effects by regulating gut microbiome, glucagon metabolism, and insulin levels in type 2 diabetic mice. Front Nutr. 2023;9:1081778.","journal-title":"Front Nutr"},{"issue":"2","key":"739_CR97","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1096\/fj.201600832R","volume":"31","author":"S Dagdeviren","year":"2017","unstructured":"Dagdeviren S, et al. IL-10 prevents aging-associated inflammation and insulin resistance in skeletal muscle. FASEB J. 2017;31(2):701.","journal-title":"FASEB J"},{"issue":"1","key":"739_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26588-x","volume":"8","author":"A Uchinaka","year":"2018","unstructured":"Uchinaka A, et al. Anti-inflammatory effects of heat-killed Lactobacillus plantarum L-137 on cardiac and adipose tissue in rats with metabolic syndrome. Sci Rep. 2018;8(1):8156.","journal-title":"Sci Rep"},{"key":"739_CR99","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00615-20","author":"HS Youn","year":"2021","unstructured":"Youn HS, Kim JH, Lee JS, Yoon YY, Choi SJ, Lee JY, Kim W, Hwang KW. Lactobacillus plantarum reduces low-grade inflammation and glucose levels in a mouse model of chronic stress and diabetes. Infect Immun. 2021;89(8):e0061520. https:\/\/doi.org\/10.1128\/IAI.00615-20.","journal-title":"Infect Immun"},{"issue":"10","key":"739_CR100","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.3390\/nu12103015","volume":"12","author":"P Toejing","year":"2021","unstructured":"Toejing P, Khat-Udomkiri N, Intakhad J, Sirilun S, Chaiyasut C, Lailerd N. Putative mechanisms responsible for the antihyperglycemic action of lactobacillus paracasei HII01 in experimental type 2 diabetic rats. Nutrients. 2021;12(10):3015.","journal-title":"Nutrients"},{"issue":"3","key":"739_CR101","first-page":"1110","volume":"10","author":"B Mahajan","year":"2019","unstructured":"Mahajan B, Snehi S, Singh V. Effect of probiotic Lactobacillus fermentum MCC3216 on progression of Type-II diabetes with their antiinflammatory activity in high fructose fed diabetic rats. Int J Pharm Sci Res. 2019;10(3):1110\u201320.","journal-title":"Int J Pharm Sci Res"},{"issue":"17","key":"739_CR102","doi-asserted-by":"publisher","first-page":"7938","DOI":"10.1039\/D1FO01571K","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, et al. Effect of Lactobacillus fermentum TKSN041 on improving streptozotocin-induced type 2 diabetes in rats. Food Funct. 2021;12(17):7938\u201353.","journal-title":"Food Funct"},{"issue":"9","key":"739_CR103","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.nut.2014.03.022","volume":"30","author":"P Chen","year":"2014","unstructured":"Chen P, et al. Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin. Nutrition. 2014;30(9):1061\u20138.","journal-title":"Nutrition"},{"key":"739_CR104","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","volume":"184","author":"JS Bhatti","year":"2022","unstructured":"Bhatti JS, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022;184:114\u201334.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"739_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107613","volume":"34","author":"S Paul","year":"2020","unstructured":"Paul S, Ali A, Katare R. Molecular complexities underlying the vascular complications of diabetes mellitus\u2013a comprehensive review. J Diabetes Complications. 2020;34(8):107613.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"739_CR106","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jcjd.2014.03.002","volume":"39","author":"O Aouacheri","year":"2015","unstructured":"Aouacheri O, Saka S, Krim M, Messaadia A, Maidi I. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can J Diabetes. 2015;39(1):44\u20139.","journal-title":"Can J Diabetes"},{"key":"739_CR107","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3708905","author":"J-R Peng","year":"2016","unstructured":"Peng J-R, Lu T-T, Chang H-T, Ge X, Huang B, Li W-M. Elevated levels of plasma superoxide dismutases 1 and 2 in patients with coronary artery disease. Biomed Res Int. 2016. https:\/\/doi.org\/10.1155\/2016\/3708905.","journal-title":"Biomed Res Int"},{"issue":"4","key":"739_CR108","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/ijms22041509","volume":"22","author":"N Eguchi","year":"2021","unstructured":"Eguchi N, Vaziri ND, Dafoe DC, Ichii H. The role of oxidative stress in pancreatic \u03b2 cell dysfunction in diabetes. Int J Mol Sci. 2021;22(4):1509.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"739_CR109","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1074\/jbc.M208359200","volume":"278","author":"YH Lee","year":"2003","unstructured":"Lee YH, Giraud J, Davis RJ, White MF. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem. 2003;278(5):2896\u2013902. https:\/\/doi.org\/10.1074\/jbc.M208359200.","journal-title":"J Biol Chem"},{"issue":"19","key":"739_CR110","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1074\/jbc.RA117.001254","volume":"293","author":"DJ Fazakerley","year":"2018","unstructured":"Fazakerley DJ, et al. Mitochondrial oxidative stress causes insulin resistance without disrupting oxidative phosphorylation. J Biol Chem. 2018;293(19):7315\u201328.","journal-title":"J Biol Chem"},{"key":"739_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061517","author":"K Wang","year":"2019","unstructured":"Wang K, Su Y, Liang Y, Song Y, Wang L. Oral DhHP-6 for the treatment of type 2 diabetes mellitus. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20061517.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"739_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081515","volume":"12","author":"Z Zeng","year":"2023","unstructured":"Zeng Z, Yang Y, Zhong X, Dai F, Chen S, Tong X. Ameliorative effects of Lactobacillus paracasei L14 on oxidative stress and gut microbiota in type 2 diabetes mellitus rats. Antioxidants. 2023;12(8):1515.","journal-title":"Antioxidants"},{"issue":"22","key":"739_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900457","volume":"63","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Yuan Q, Yu R, Zhang J, Ma H, Chen S. Ameliorative effects of probiotic Lactobacillus paracasei NL41 on insulin sensitivity, oxidative stress, and beta-cell function in a type 2 diabetes mellitus rat model. Mol Nutr Food Res. 2019;63(22):1900457.","journal-title":"Mol Nutr Food Res"},{"key":"739_CR114","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-023-10159-2","author":"N Talib","year":"2023","unstructured":"Talib N, Mohamad NE, Yeap SK, Ho CL, Masarudin MJ, Abd-Aziz S, Izham MNM,Kumar MR, Hussin Y, Alitheen NB. Anti-diabetic effect of lactobacillus paracasei isolated from malaysian water kefir grains. Probiotics Antimicrob Proteins. 2024;16(6):2161\u20132180. https:\/\/doi.org\/10.1007\/s12602-023-10159-2.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"14","key":"739_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24142606","volume":"24","author":"N Talib","year":"2019","unstructured":"Talib N, et al. Isolation and characterization of Lactobacillus spp. from kefir samples in Malaysia. Molecules. 2019;24(14):2606.","journal-title":"Molecules"},{"issue":"4","key":"739_CR116","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/plants8040096","volume":"8","author":"S Aryal","year":"2019","unstructured":"Aryal S, Baniya MK, Danekhu K, Kunwar P, Gurung R, Koirala N. Total phenolic content, flavonoid content and antioxidant potential of wild vegetables from Western Nepal. Plants. 2019;8(4):96.","journal-title":"Plants"},{"issue":"5","key":"739_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7050062","volume":"7","author":"C Gaucher","year":"2018","unstructured":"Gaucher C, Boudier A, Bonetti J, Clarot I, Leroy P, Parent M. Glutathione: antioxidant properties dedicated to nanotechnologies. Antioxidants. 2018;7(5):62.","journal-title":"Antioxidants"},{"issue":"9","key":"739_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13899","volume":"45","author":"F Yang","year":"2021","unstructured":"Yang F, et al. Hypoglycemic effects of space-induced Lactobacillus plantarum SS18\u20105 on type 2 diabetes in a rat model. J Food Biochem. 2021;45(9):e13899.","journal-title":"J Food Biochem"},{"issue":"1","key":"739_CR119","first-page":"297","volume":"20","author":"X Meng","year":"2022","unstructured":"Meng X, et al. Anti-oxidative stress properties by Lactiplantibacillus plantarum SCS3 in streptozotocin-induced diabetic mice. CyTA. 2022;20(1):297\u2013304.","journal-title":"CyTA"},{"issue":"9","key":"739_CR120","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14256","volume":"46","author":"X Meng","year":"2022","unstructured":"Meng X, Chen C, Sun J, Jing L, Zuo L, Wu L. Alleviation of oxidative stress in pancreatic tissue of hyperglycemic mice by Lactiplantibacillus plantarum SCS4. J Food Biochem. 2022;46(9):e14256.","journal-title":"J Food Biochem"},{"issue":"2","key":"739_CR121","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2298\/ABS190123008K","volume":"71","author":"A Korkmaz \u00d6mer","year":"2019","unstructured":"Korkmaz \u00d6mer A, Sadi G, Kocaba\u015f A, Yildirim OG, Sumlu E, Koca HB, Nalbantoglu B, Pekta\u015f MB, Akar F. Lactobacillus helveticus and Lactobacillus plantarum modulate renal antioxidant status in a rat model of fructose-inducedmetabolic syndrome. Arch Biol Sci [Internet]. 2019 [cited 2026Feb.13];71(2):265\u201373. Available from: https:\/\/doi.org\/10.2298\/ABS190123008K.","journal-title":"Arch Biol Sci [Internet]"},{"issue":"7","key":"739_CR122","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.2337\/db11-1241","volume":"61","author":"AM Faria","year":"2012","unstructured":"Faria AM, Papadimitriou A, Silva KC, de Lopes Faria JM, de Lopes Faria JB. Uncoupling endothelial nitric oxide synthase is ameliorated by green tea in experimental diabetes by re-establishing tetrahydrobiopterin levels. Diabetes. 2012;61(7):1838\u201347.","journal-title":"Diabetes"},{"issue":"6","key":"739_CR123","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/jam.12461","volume":"116","author":"C Hou","year":"2014","unstructured":"Hou C, Zhang J, Liu X, Liu H, Zeng X, Qiao S. Superoxide dismutase recombinant Lactobacillus fermentum ameliorates intestinal oxidative stress through inhibiting NF-\u03ba B activation in a trinitrobenzene sulphonic acid\u2010induced colitis mouse model. J Appl Microbiol. 2014;116(6):1621\u201331.","journal-title":"J Appl Microbiol"},{"issue":"12","key":"739_CR124","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1039\/C8FO01768A","volume":"9","author":"B Li","year":"2018","unstructured":"Li B, et al. Lactobacillus helveticus KLDS1. 8701 alleviates d-galactose-induced aging by regulating Nrf-2 and gut microbiota in mice. Food Funct. 2018;9(12):6586\u201398.","journal-title":"Food Funct"},{"issue":"3","key":"739_CR125","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1039\/C8FO01920G","volume":"10","author":"B Li","year":"2019","unstructured":"Li B, et al. In vitro and in vivo evaluation of an exopolysaccharide produced by Lactobacillus helveticus KLDS1. 8701 for the alleviative effect on oxidative stress. Food Funct. 2019;10(3):1707\u201317.","journal-title":"Food Funct"},{"key":"739_CR126","doi-asserted-by":"publisher","unstructured":"NamY et al. Heat-killed Lactiplantibacillus plantarum LRCC5314 mitigates the effects of stress-related type 2 diabetes in mice via gut microbiome modulation. 2022;32(3):324-332. https:\/\/doi.org\/10.4014\/jmb.2111.11008.","DOI":"10.4014\/jmb.2111.11008"},{"issue":"2","key":"739_CR127","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1039\/D1FO02387J","volume":"13","author":"G Wang","year":"2022","unstructured":"Wang G, et al. Lactobacillus plantarum SHY130 isolated from Yak yogurt attenuates hyperglycemia in C57BL\/6J mice by regulating the enteroinsular axis. Food Funct. 2022;13(2):675\u201387.","journal-title":"Food Funct"},{"issue":"6","key":"739_CR128","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1002\/jsfa.12267","volume":"103","author":"Y Gu","year":"2023","unstructured":"Gu Y, et al. Lactobacillus paracasei IMC 502 ameliorates type 2 diabetes by mediating gut microbiota\u2013SCFA\u2013hormone\/inflammation pathway in mice. J Sci Food Agric. 2023;103(6):2949\u201359.","journal-title":"J Sci Food Agric"},{"key":"739_CR129","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12020-019-02103-8","volume":"66","author":"L Zhao","year":"2019","unstructured":"Zhao L, Lou H, Peng Y, Chen S, Zhang Y, Li X. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine. 2019;66:526\u201337.","journal-title":"Endocrine"},{"key":"739_CR130","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-6717","author":"L Li","year":"2020","unstructured":"Li L, Li C, Lv M, Hu Q, Guo L, Xiong D. Correlation between alterations of gut microbiota and miR-122-5p expression in patients with type 2 diabetes mellitus. Ann Transl Med. 2020. https:\/\/doi.org\/10.21037\/atm-20-6717.","journal-title":"Ann Transl Med"},{"issue":"1","key":"739_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/srep32484","volume":"6","author":"S Rabot","year":"2016","unstructured":"Rabot S, et al. High fat diet drives obesity regardless the composition of gut microbiota in mice. Sci Rep. 2016;6(1):32484.","journal-title":"Sci Rep"},{"key":"739_CR132","doi-asserted-by":"publisher","unstructured":"Bahar-TokmanH et al. Firmicutes\/Bacteroidetes ratio in the gut microbiota and IL-1\u03b2, IL-6, IL-8, TLR2, TLR4, TLR5 gene expressions in type 2 diabetes. Clin Lab. 2022;68(9). https:\/\/doi.org\/10.7754\/Clin.Lab.2022.211244.","DOI":"10.7754\/Clin.Lab.2022.211244"},{"key":"739_CR133","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21149\/8133","volume":"60","author":"YC Orbe-Orihuela","year":"2018","unstructured":"Orbe-Orihuela YC, et al. High relative abundance of firmicutes and increased TNF-\u03b1 levels correlate with obesity in children. Salud p\u00fablica De M\u00e9xico. 2018;60:5\u201311.","journal-title":"Salud p\u00fablica De M\u00e9xico"},{"key":"739_CR134","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40801-020-00206-7","volume":"7","author":"NK Polavarapu","year":"2020","unstructured":"Polavarapu NK, et al. Effect of Gliclazide or Gliclazide plus Metformin combination on glycemic control in patients with T2DM in india: a real-world, retrospective, longitudinal, observational study from electronic medical records. Drugs-Real World Outcomes. 2020;7:271\u20139.","journal-title":"Drugs-Real World Outcomes"},{"issue":"5","key":"739_CR135","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5409\/wjcp.v10.i5.84","volume":"10","author":"LB Zhu","year":"2021","unstructured":"Zhu LB, Zhang YC, Huang HH, Lin J. Prospects for clinical applications of butyrate-producing bacteria. World J Clin Pediatr. 2021;10(5):84\u201392. https:\/\/doi.org\/10.5409\/wjcp.v10.i5.84.","journal-title":"World J Clin Pediatr"},{"issue":"5","key":"739_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051474","volume":"12","author":"F Magne","year":"2020","unstructured":"Magne F, et al. The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients. 2020;12(5):1474.","journal-title":"Nutrients"},{"issue":"1","key":"739_CR137","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2057778","volume":"14","author":"L Henneke","year":"2022","unstructured":"Henneke L, et al. A dietary carbohydrate\u2013gut Parasutterella\u2013human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes. Gut microbes. 2022;14(1):2057778.","journal-title":"Gut microbes"},{"key":"739_CR138","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15193","volume":"11","author":"Y Lv","year":"2023","unstructured":"Lv Y, et al. Alterations of the gut microbiota in type 2 diabetics with or without subclinical hypothyroidism. PeerJ. 2023;11:e15193.","journal-title":"PeerJ"},{"issue":"15","key":"739_CR139","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1039\/D1FO00515D","volume":"12","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Guo X, Zhang J, Yuan Q, Chen S. Lactobacillus paracasei modulates the gut microbiota and improves inflammation in type 2 diabetic rats. Food Funct. 2021;12(15):6809\u201320.","journal-title":"Food Funct"},{"key":"739_CR140","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8406846","author":"J Cai","year":"2020","unstructured":"Cai J, et al. Alteration of intestinal microbiota in 3-deoxyglucosone-induced prediabetic rats. Biomed Res Int. 2020. https:\/\/doi.org\/10.1155\/2020\/8406846.","journal-title":"Biomed Res Int"},{"key":"739_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00173","volume":"11","author":"L Han","year":"2020","unstructured":"Han L, et al. A novel antidiabetic monomers combination alleviates insulin resistance through bacteria-cometabolism-inflammation responses. Front Microbiol. 2020;11:173.","journal-title":"Front Microbiol"},{"key":"739_CR142","doi-asserted-by":"publisher","first-page":"131106","DOI":"10.1016\/j.foodchem.2021.131106","volume":"371","author":"Q Nie","year":"2022","unstructured":"Nie Q, Hu J, Chen H, Geng F, Nie S. Arabinoxylan ameliorates type 2 diabetes by regulating the gut microbiota and metabolites. Food Chem. 2022;371:131106.","journal-title":"Food Chem"},{"key":"739_CR143","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.abb.2017.07.016","volume":"630","author":"AE Achari","year":"2017","unstructured":"Achari AE, Jain SK. L-Cysteine supplementation increases insulin sensitivity mediated by upregulation of GSH and adiponectin in high glucose treated 3T3-L1 adipocytes. Arch Biochem Biophys. 2017;630:54\u201365.","journal-title":"Arch Biochem Biophys"},{"key":"739_CR144","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S301454","author":"T Wei","year":"2021","unstructured":"Wei T, Jia Y, Xue W, Ma M, Wu W. Nutritional effects of the enteral nutritional formula on regulation of gut microbiota and metabolic level in type 2 diabetes mellitus mice. Diabetes Metab Syndr Obes. 2021;28;14:1855\u20131869. https:\/\/doi.org\/10.2147\/DMSO.S301454.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"16","key":"739_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100536","volume":"8","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Adv Sci. 2021;8(16):2100536.","journal-title":"Adv Sci"},{"issue":"9","key":"739_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8091360","volume":"8","author":"C-T Shih","year":"2020","unstructured":"Shih C-T, Yeh Y-T, Lin C-C, Yang L-Y, Chiang C-P. Akkermansia muciniphila is negatively correlated with hemoglobin A1c in refractory diabetes. Microorganisms. 2020;8(9):1360.","journal-title":"Microorganisms"},{"key":"739_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1004617","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, et al. Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice. Front Pharmacol. 2022;13:1004617.","journal-title":"Front Pharmacol"},{"issue":"1","key":"739_CR148","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1832857","volume":"12","author":"L Ma","year":"2020","unstructured":"Ma L, et al. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes. 2020;12(1):1832857.","journal-title":"Gut Microbes"},{"key":"739_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01271","volume":"10","author":"D Wu","year":"2019","unstructured":"Wu D, Ding L, Tang X, Wang W, Chen Y, Zhang T. Baicalin protects against hypertension-associated intestinal barrier impairment in part through enhanced microbial production of short-chain fatty acids. Front Pharmacol. 2019;10:1271.","journal-title":"Front Pharmacol"},{"issue":"6","key":"739_CR150","doi-asserted-by":"publisher","first-page":"e0179586","DOI":"10.1371\/journal.pone.0179586","volume":"12","author":"H Yan","year":"2017","unstructured":"Yan H, Ajuwon KM. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLoS One. 2017;12(6):e0179586.","journal-title":"PLoS One"},{"key":"739_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2021.110717","volume":"150","author":"T Xia","year":"2021","unstructured":"Xia T, et al. Coix seed polysaccharides alleviate type 2 diabetes mellitus via gut microbiota-derived short-chain fatty acids activation of IGF1\/PI3K\/AKT signaling. Food Res Int. 2021;150:110717.","journal-title":"Food Res Int"},{"issue":"1","key":"739_CR152","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pcad.2018.12.004","volume":"62","author":"D Laddu","year":"2019","unstructured":"Laddu D, Hauser M. Addressing the nutritional phenotype through personalized nutrition for chronic disease prevention and management. Prog Cardiovasc Dis. 2019;62(1):9\u201314. https:\/\/doi.org\/10.1016\/j.pcad.2018.12.004.","journal-title":"Prog Cardiovasc Dis"},{"key":"739_CR153","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tifs.2022.08.017","volume":"128","author":"KM Livingstone","year":"2022","unstructured":"Livingstone KM, Ramos-Lopez O, P\u00e9russe L, Kato H, Ordovas JM, Mart\u00ednez JA. Precision nutrition: a review of current approaches and future endeavors. Trends Food Sci Technol. 2022;128:253\u201364. https:\/\/doi.org\/10.1016\/j.tifs.2022.08.017.","journal-title":"Trends Food Sci Technol"},{"key":"739_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.682290","volume":"12","author":"X Ai","year":"2021","unstructured":"Ai X, et al. Antidiabetic function of Lactobacillus fermentum MF423-fermented rice bran and its effect on gut microbiota structure in type 2 diabetic mice. Front Microbiol. 2021;12:682290.","journal-title":"Front Microbiol"},{"key":"739_CR155","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6369873","volume":"2020","author":"L Hartajanie","year":"2020","unstructured":"Hartajanie L, Fatimah-Muis S, Heri-Nugroho Hs K, Riwanto I, Sulchan M. Probiotics fermented bitter melon juice as promising complementary agent for diabetes type 2: study on animal model. J Nutr Metab. 2020;2020:6369873. https:\/\/doi.org\/10.1155\/2020\/6369873.","journal-title":"J Nutr Metab"},{"issue":"49","key":"739_CR156","doi-asserted-by":"publisher","first-page":"11884","DOI":"10.1021\/jf503681r","volume":"62","author":"C Li","year":"2014","unstructured":"Li C, Ding Q, Nie SP, Zhang YS, Xiong T, Xie MY. Carrot juice fermented with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats. J Agric Food Chem. 2014;62(49):11884\u201391. https:\/\/doi.org\/10.1021\/jf503681r.","journal-title":"J Agric Food Chem"},{"issue":"10","key":"739_CR157","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.3390\/molecules26102868","volume":"26","author":"A Frediansyah","year":"2021","unstructured":"Frediansyah A, Romadhoni F, Suryani R, Nurhayati, Wibowo AT. Fermentation of Jamaican cherries juice using Lactobacillus plantarum elevates antioxidant potential and inhibitory activity against Type II diabetes-related enzymes. Molecules. 2021;26(10):2868.","journal-title":"Molecules"},{"key":"739_CR158","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nutres.2022.10.003","volume":"108","author":"AN El-Dein","year":"2022","unstructured":"El-Dein AN, Ezzat A, Aly HF, Awad G, Farid M. Lactobacillus-fermented yogurt exerts hypoglycemic, hypocholesterolemic, and anti-inflammatory activities in STZ-induced diabetic Wistar rats. Nutr Res. 2022;108:22\u201332.","journal-title":"Nutr Res"},{"key":"739_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13060740","author":"K Kamonsuwan","year":"2024","unstructured":"Kamonsuwan K, et al. Black Goji berry (Lycium ruthenicum) juice fermented with Lactobacillus rhamnosus GG enhances inhibitory activity against dipeptidyl peptidase-IV and key steps of lipid digestion and absorption. Antioxidants. 2024. https:\/\/doi.org\/10.3390\/antiox13060740.","journal-title":"Antioxidants"},{"issue":"48","key":"739_CR160","doi-asserted-by":"publisher","first-page":"12696","DOI":"10.1021\/acs.jafc.8b04874","volume":"66","author":"L Qu","year":"2018","unstructured":"Qu L, et al. Antidiabetic effects of Lactobacillus casei fermented yogurt through reshaping gut microbiota structure in type 2 diabetic rats. J Agric Food Chem. 2018;66(48):12696\u2013705.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"739_CR161","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3168\/jds.2018-15203","volume":"102","author":"M Niibo","year":"2019","unstructured":"Niibo M, et al. Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model. J Dairy Sci. 2019;102(2):997\u20131006.","journal-title":"J Dairy Sci"},{"key":"739_CR162","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.foodres.2019.03.055","volume":"121","author":"H Gao","year":"2019","unstructured":"Gao H, et al. Fermented momordica Charantia L. juice modulates hyperglycemia, lipid profile, and gut microbiota in type 2 diabetic rats. Food Res Int. 2019;121:367\u201378.","journal-title":"Food Res Int"},{"key":"739_CR163","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s13213-019-01518-y","volume":"69","author":"DR Oliveira","year":"2019","unstructured":"Oliveira DR, Lopes ACA, Pereira RA, Cardoso PG, Duarte WF. Selection of potentially probiotic Kluyveromyces lactis for the fermentation of cheese whey\u2013based beverage. Ann Microbiol. 2019;69:1361\u201372.","journal-title":"Ann Microbiol"},{"key":"739_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.lwt.2022.113709","volume":"165","author":"N Hadinia","year":"2022","unstructured":"Hadinia N, Dovom MRE, Yavarmanesh M. The effect of fermentation conditions (temperature, salt concentration, and pH) with lactobacillus strains for producing short chain fatty acids. LWT. 2022;165:113709.","journal-title":"LWT"},{"issue":"4","key":"739_CR165","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4014\/jmb.2002.02052","volume":"30","author":"KJ Han","year":"2020","unstructured":"Han KJ, Lee J-E, Lee N-K, Paik H-D. Antioxidant and anti-inflammatory effect of probiotic Lactobacillus plantarum KU15149 derived from Korean homemade diced-radish Kimchi. J Microbiol Biotechnol. 2020;30(4):591.","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"739_CR166","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/fsn3.2662","volume":"10","author":"C Liu","year":"2022","unstructured":"Liu C, Han F, Cong L, Sun T, Menghe B, Liu W. Evaluation of tolerance to artificial gastroenteric juice and fermentation characteristics of Lactobacillus strains isolated from human. Food Sci Nutr. 2022;10(1):227\u201338.","journal-title":"Food Sci Nutr"},{"issue":"22","key":"739_CR167","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jafc.1c00719","volume":"69","author":"C He","year":"2021","unstructured":"He C, Sampers I, de Van Walle D, Dewettinck K, Raes K. Encapsulation of Lactobacillus in low-methoxyl pectin-based microcapsules stimulates biofilm formation: enhanced resistances to heat shock and simulated gastrointestinal digestion. J Agric Food Chem. 2021;69(22):6281\u201390.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"739_CR168","doi-asserted-by":"publisher","first-page":"20550","DOI":"10.1038\/s41598-021-00077-0","volume":"11","author":"EL Lasta","year":"2021","unstructured":"Lasta EL, da Silva Pereira Ronning E, Dekker RF, da Cunha MAA. Encapsulation and dispersion of Lactobacillus acidophilus in a chocolate coating as a strategy for maintaining cell viability in cereal bars. Sci Rep. 2021;11(1):20550.","journal-title":"Sci Rep"},{"issue":"10","key":"739_CR169","doi-asserted-by":"publisher","first-page":"8694","DOI":"10.1039\/D0FO01394C","volume":"11","author":"D Arepally","year":"2020","unstructured":"Arepally D, Reddy RS, Goswami TK. Encapsulation of Lactobacillus acidophilus NCDC 016 cells by spray drying: characterization, survival after in vitro digestion, and storage stability. Food & Function. 2020;11(10):8694\u2013706.","journal-title":"Food & Function"},{"issue":"5","key":"739_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/foods11050740","volume":"11","author":"A Varela-P\u00e9rez","year":"2022","unstructured":"Varela-P\u00e9rez A, et al. Encapsulation of Lactobacillus gasseri: characterization, probiotic survival, in vitro evaluation and viability in apple juice. Foods. 2022;11(5):740.","journal-title":"Foods"},{"issue":"1","key":"739_CR171","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/1471-0307.12909","volume":"76","author":"Y Nami","year":"2023","unstructured":"Nami Y, Kiani A, Elieh-Ali-Komi D, Jafari M, Haghshenas B. Impacts of alginate\u2013basil seed mucilage\u2013prebiotic microencapsulation on the survival rate of the potential probiotic leuconostoc mesenteroides ABRIINW.N18 in yogurt. Int J Dairy Technol. 2023;76(1):138\u201348. https:\/\/doi.org\/10.1111\/1471-0307.12909.","journal-title":"Int J Dairy Technol"},{"key":"739_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105521","volume":"104","author":"P Hradicka","year":"2023","unstructured":"Hradicka P, Adamkova P, Lenhardt L, Gancarcikova S, Iannaccone SF, Demeckova V. Addressing safety concerns of long-term probiotic use: in vivo evidence from a rat model. J Funct Foods. 2023;104:105521.","journal-title":"J Funct Foods"},{"issue":"6","key":"739_CR173","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-249020","volume":"15","author":"C Karime","year":"2022","unstructured":"Karime C, Barrios MS, Wiest NE, Stancampiano F. Lactobacillus rhamnosus sepsis, endocarditis and septic emboli in a patient with ulcerative colitis taking probiotics. BMJ Case Rep. 2022;15(6):e249020.","journal-title":"BMJ Case Rep"},{"issue":"3","key":"739_CR174","first-page":"394","volume":"31","author":"G Carrega","year":"2023","unstructured":"Carrega G, et al. Vertebral osteomyelitis due to Lactobacillus paracasei in a diabetic patient. A case report and literature review. Le Infezioni in Medicina. 2023;31(3):394.","journal-title":"Le Infezioni in Medicina"},{"key":"739_CR175","doi-asserted-by":"crossref","unstructured":"Rahman A, Alqaisi S, Nath J. A Case of Lactobacillus casei Endocarditis Associated With Probiotic Intake in an Immunocompromised Patient. Cureus. 2023;15(4).","DOI":"10.7759\/cureus.38049"},{"issue":"5","key":"739_CR176","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cgh.2018.01.018","volume":"17","author":"C De Simone","year":"2019","unstructured":"De Simone C. The unregulated probiotic market. Clin Gastroenterol Hepatol. 2019;17(5):809\u201317.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"739_CR177","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.japh.2016.07.001","volume":"56","author":"ME Sanders","year":"2016","unstructured":"Sanders ME, et al. Probiotic use in at-risk populations. J Am Pharmacists Association. 2016;56(6):680\u20136.","journal-title":"J Am Pharmacists Association"},{"key":"739_CR178","unstructured":"Food US, Drug A. Early Clinical Trials With Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information; Guidance for Industry, U.S. Food and Drug Administration, 2016. [Online]. Available: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/early-clinical-trials-live-biotherapeutic-products-chemistry-manufacturing-and-control-information"},{"issue":"1","key":"739_CR179","doi-asserted-by":"publisher","first-page":"e8517","DOI":"10.2903\/j.efsa.2024.8517","volume":"22","author":"K Koutsoumanis","year":"2024","unstructured":"Koutsoumanis K, et al. Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 19: Suitability of taxonomic units notified to EFSA until September 2023, (in eng). Efsa j. 2024;22(1):e8517. https:\/\/doi.org\/10.2903\/j.efsa.2024.8517.","journal-title":"Efsa j"},{"key":"739_CR180","doi-asserted-by":"publisher","unstructured":"T\u00f3th AG, Judge MF, Nagy S, Papp M, Solymosi N. A survey on antimicrobial resistance genes of frequently used probiotic bacteria, 1901 to 2022, (in eng). Euro Surveill. 2023;28(14). https:\/\/doi.org\/10.2807\/1560-7917.Es.2023.28.14.2200272","DOI":"10.2807\/1560-7917.Es.2023.28.14.2200272"},{"issue":"11","key":"739_CR181","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/antibiotics11111557","volume":"11","author":"E Anisimova","year":"2022","unstructured":"Anisimova E, Gorokhova I, Karimullina G, Yarullina D. Alarming antibiotic resistance of lactobacilli isolated from probiotic preparations and dietary supplements. Antibiotics. 2022;11(11):1557. https:\/\/www.mdpi.com\/2079-6382\/11\/11\/1557.","journal-title":"Antibiotics"},{"issue":"14","key":"739_CR182","doi-asserted-by":"publisher","first-page":"2200272","DOI":"10.2807\/1560-7917.ES.2023.28.14.2200272","volume":"28","author":"AG T\u00f3th","year":"2023","unstructured":"T\u00f3th AG, Judge MF, Nagy S\u00c1, Papp M, Solymosi N. A survey on antimicrobial resistance genes of frequently used probiotic bacteria, 1901 to 2022. Eurosurveillance. 2023;28(14):2200272. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.14.2200272.","journal-title":"Eurosurveillance"},{"issue":"12","key":"739_CR183","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.mayocp.2017.10.004","volume":"92","author":"PC Kashyap","year":"2017","unstructured":"Kashyap PC, Chia N, Nelson H, Segal E, Elinav E. Microbiome at the frontier of personalized medicine. Mayo Clin Proc. 2017;92(12):1855\u201364. https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.004.","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"739_CR184","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.4239\/wjd.v12.i7.1070","volume":"12","author":"S Wang","year":"2021","unstructured":"Wang S, Yong H, He XD. Multi-omics: opportunities for research on mechanism of type 2 diabetes mellitus. World J Diabetes. 2021;12(7):1070\u201380. https:\/\/doi.org\/10.4239\/wjd.v12.i7.1070.","journal-title":"World J Diabetes"},{"issue":"3","key":"739_CR185","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.mjafi.2021.06.021","volume":"77","author":"N Naithani","year":"2021","unstructured":"Naithani N, Sinha S, Misra P, Vasudevan B, Sahu R Precision medicine: concept and tools. Med J Armed Forces India. 2021;77(3):249\u201357. https:\/\/doi.org\/10.1016\/j.mjafi.2021.06.021.","journal-title":"Med J Armed Forces India Jul"},{"key":"739_CR186","doi-asserted-by":"publisher","unstructured":"Dhieb D et al. Harnessing pharmacomultiomics for precision medicine in diabetes: a comprehensive review, (in eng). Biomedicines. 2025;13(2). https:\/\/doi.org\/10.3390\/biomedicines13020447.","DOI":"10.3390\/biomedicines13020447"},{"issue":"30","key":"739_CR187","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/advances\/nmaa133","volume":"12","author":"T Rittiphairoj","year":"2021","unstructured":"Rittiphairoj T, Pongpirul K, Janchot K, Mueller NT, Li T. Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis, (in eng). Adv Nutr. 2021;12(30):722\u201334. https:\/\/doi.org\/10.1093\/advances\/nmaa133.","journal-title":"Adv Nutr"},{"key":"739_CR188","doi-asserted-by":"publisher","unstructured":"Vinderola G, Sanders ME, Salminen S. The concept of postbiotics, (in eng). Foods. 2022;11(8). https:\/\/doi.org\/10.3390\/foods11081077.","DOI":"10.3390\/foods11081077"},{"key":"739_CR189","doi-asserted-by":"publisher","unstructured":"Wang Y, Tian L, Fabi JP, de Vos P. The potential of prebiotics, probiotics, and synbiotics for ameliorating intestinal barrier dysfunction and modulating inflammatory responses as dietary supplements in diabetes mellitus management. Food Bioscience. 2025;72:107539, 2025\/10\/01\/. https:\/\/doi.org\/10.1016\/j.fbio.2025.107539.","DOI":"10.1016\/j.fbio.2025.107539"},{"key":"739_CR190","doi-asserted-by":"publisher","unstructured":"Zhao C et al. Lactobacillus acidophilus YL01 and its exopolysaccharides ameliorate obesity and insulin resistance in obese mice via modulating intestinal specific bacterial groups and AMPK\/ACC signaling pathway. Int J Biol Macromol. 2025;300: 140287, 2025\/04\/01\/. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140287.","DOI":"10.1016\/j.ijbiomac.2025.140287"},{"issue":"9","key":"739_CR191","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, et al The international scientific association of probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics, (in eng). Nat Rev Gastroenterol Hepatol. 2021;18(9):649\u201367. https:\/\/doi.org\/10.1038\/s41575-021-00440-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"739_CR192","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12986-025-01037-5","volume":"22","author":"S Li","year":"2025","unstructured":"Li S, Sohouli MH, Li Z The effect of postbiotics supplementation on obesity and metabolic health: a systematic review and meta-analysis of randomized control trials, (in eng). Nutr Metab (Lond). 2025;22(1):140. https:\/\/doi.org\/10.1186\/s12986-025-01037-5.","journal-title":"Nutr Metab (Lond)"},{"issue":"1","key":"739_CR193","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12020-023-03606-1","volume":"84","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Efficacy of fecal microbiota transplantation in type 2 diabetes mellitus: a systematic review and meta-analysis, (in eng). Endocrine. 2024;84(1):48\u201362. https:\/\/doi.org\/10.1007\/s12020-023-03606-1.","journal-title":"Endocrine"},{"key":"739_CR194","doi-asserted-by":"publisher","first-page":"1370999","DOI":"10.3389\/fcimb.2024.1370999","volume":"14","author":"J Zhang","year":"2024","unstructured":"Zhang J, et al. Advances in fecal microbiota transplantation for the treatment of diabetes mellitus, (in eng). Front Cell Infect Microbiol. 2024;14:1370999. https:\/\/doi.org\/10.3389\/fcimb.2024.1370999.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"739_CR195","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7570\/jomes25014","volume":"34","author":"S Piwchan","year":"2025","unstructured":"Piwchan S, et al. Fecal microbiota transplantation by rectal enema improves short-term insulin resistance in metabolic syndrome: s pilot randomized controlled trial, (in eng). JOMES. 2025;34(4):434\u201345. https:\/\/doi.org\/10.7570\/jomes25014.","journal-title":"JOMES"},{"key":"739_CR196","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.copbio.2018.11.009","volume":"56","author":"YJ Goh","year":"2019","unstructured":"Goh YJ, Barrangou R Harnessing CRISPR-Cas systems for precision engineering of designer probiotic lactobacilli, (in eng). Curr Opin Biotechnol. 2019;56:163\u201371. https:\/\/doi.org\/10.1016\/j.copbio.2018.11.009.","journal-title":"Curr Opin Biotechnol"},{"key":"739_CR197","doi-asserted-by":"publisher","unstructured":"Mugwanda K et al. Recent advances in genetic tools for engineering probiotic lactic acid bacteria, (in eng). Biosci Rep. 2023;43(1). https:\/\/doi.org\/10.1042\/bsr20211299.","DOI":"10.1042\/bsr20211299"},{"issue":"7","key":"739_CR198","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1039\/D3FO00044C","volume":"14","author":"H Hu","year":"2023","unstructured":"Hu H, et al. Improvement effect of a next-generation probiotic L. plantarum-pMG36e-GLP-1 on type 2 diabetes mellitus via the gut-pancreas-liver axis, (in eng). Food Funct. 2023;14(7):3179\u201395. https:\/\/doi.org\/10.1039\/d3fo00044c.","journal-title":"Food Funct"},{"key":"739_CR199","doi-asserted-by":"publisher","first-page":"6675676","DOI":"10.1155\/cjid\/6675676","volume":"2025","author":"J Luo","year":"2025","unstructured":"Luo J, et al. Administration of a Next-Generation Probiotic Escherichia coli Nissle 1917-GLP-1 Alleviates Diabetes in Mice With Type 1 and Type 2 Diabetes, (in eng). Can J Infect Dis Med Microbiol. 2025;2025:6675676. https:\/\/doi.org\/10.1155\/cjid\/6675676.","journal-title":"Can J Infect Dis Med Microbiol"}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-026-00739-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13668-026-00739-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-026-00739-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:18:26Z","timestamp":1781637506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13668-026-00739-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":199,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s13668-026-00739-3","relation":{},"ISSN":["2161-3311"],"issn-type":[{"value":"2161-3311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}